IP Library Granted Patent US 12,290,643
Granted Patent B2
US 12,290,643 · App. 18/312,674 · Granted May 6, 2025

Extension tube assembly and related medical fluid transfer systems and methods

Inventor: Peter G. Piferi (Orange, CA)
Assignee: ClearPoint Neuro, Inc.
A61M25/0097A61B90/11A61M25/0023A61M25/0084A61M39/10A61M2025/0089A61M2039/1077
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,643
App. No.
18/312,674
Granted
May 6, 2025
Kind
B2
Abstract

Devices for transferring fluid to or from a subject include an extension tube assembly with an axially extending inner tube configured to couple to an elongate tubular cannula having opposing proximal and distal ends with an axially extending lumen and an axially extending inner tube. The inner tube extending through the tubular cannula defines an exposed needle tip and is in fluid communication with the inner tube of the extension tube assembly. The needle tip extends out of a distal end of the tubular cannula a suitable distance.

Claims (36)

1. A medical intrabody fluid transfer system, comprising:

(i) an extension tube assembly comprising:

an outer support tube having an inner lumen and a length and opposing first and second end portions;

an inner tube longitudinally extending inside the inner lumen of the outer support tube and defining a longitudinally extending open fluid flow path;

a first connector coupled to the first end portion of the outer support tube; and

a second connector coupled to the second end portion of the outer support tube,

wherein the inner tube extends out of the first end portion of the outer support tube into the first connector, and wherein the inner tube extends out of the second end portion of the outer support tube into the second connector;

(ii) a cannula assembly coupled to the extension tube assembly and that resides distal of the extension tube assembly, the cannula assembly comprising:

a tubular cannula having opposing proximal and distal ends with an open axially extending lumen; and

an elongate inner tube extending through the lumen of the tubular cannula with a distal end defining an exposed needle tip; and

(iii) a flexible tubing assembly comprising:

flexible tubing;

a distal connector coupled to a distal end of the flexible tubing and a proximal end of the tubular cannula;

a proximal connector coupled to a proximal end of the flexible tubing and coupled to the first or second connector of the extension tube assembly; and

an inner tube in the flexible tubing aligned with and in fluid communication with the inner tube extending through the tubular cannula and the inner tube of the extension tube assembly,

wherein the extension tube assembly further comprises:

a coupling tube extending a distance into the inner lumen of the outer support tube at the first end portion of the outer support tube and extending a distance out of the inner lumen and into the first connector, wherein the coupling tube is closely spaced apart from and surrounds the inner tube and has a length that is in a range of about 0.1 inches and about 1 inch; and

an adapter sleeve coupled to an outer surface of the outer support tube and an outer surface of the first connector.

2. The system of claim 1 , wherein an outer surface of the tubular cannula has a size and geometry adapted for use with a stereotactic frame with a trajectory guide having a support column sized and configured to releasably hold the tubular cannula so that at least a portion of the tubular cannula resides above the support column, and wherein the inner tube of the extension tube assembly, the inner tube of the flexible tubing assembly and the inner tube extending through the tubular cannula all have an inner diameter of in a range of about 100 μm and about 750 μm.

3. The system of claim 2 , wherein the inner tube of the extension tube assembly, the inner tube of the flexible tubing assembly and the inner tube extending through the tubular cannula all have an inner diameter that is the same, on average, over a respective length.

4. A medical intrabody fluid transfer system, comprising:

(i) an extension tube assembly comprising:

an outer support tube having an inner lumen and a length and opposing first and second end portions;

an inner tube longitudinally extending inside the inner lumen of the outer support tube and defining a longitudinally extending open fluid flow path;

a first connector coupled to the first end portion of the outer support tube; and

a second connector coupled to the second end portion of the outer support tube,

wherein the inner tube extends out of the first end portion of the outer support tube into the first connector, and wherein the inner tube extends out of the second end portion of the outer support tube into the second connector;

(ii) a cannula assembly coupled to the extension tube assembly and that resides distal of the extension tube assembly, the cannula assembly comprising:

a tubular cannula having opposing proximal and distal ends with an open axially extending lumen; and

an elongate inner tube extending through the lumen of the tubular cannula with a distal end defining an exposed needle tip; and

(iii) a flexible tubing assembly comprising:

flexible tubing;

a distal connector coupled to a distal end of the flexible tubing and a proximal end of the tubular cannula;

a proximal connector coupled to a proximal end of the flexible tubing and coupled to the first or second connector of the extension tube assembly; and

an inner tube in the flexible tubing aligned with and in fluid communication with the inner tube extending through the tubular cannula and the inner tube of the extension tube assembly,

wherein the second connector has an outer wall surrounding an inner channel, wherein the inner channel has a first segment that holds the second end portion of the outer support tube, wherein the second connector comprises a projecting member that is axially aligned with and has an end that extends forward of the outer support tube and out of the outer wall of the second connector, wherein the second connector comprises an open cavity between the outer wall and the projecting member, wherein the projecting member has a tapered axially extending channel, and wherein the inner tube extends through the tapered axially extending channel and terminates at the end of the projecting member.

Assignments (3)
SECURITY INTEREST Recorded May 13, 2025
From: CLEARPOINT NEURO, INC.
To: CALW SA LLC, AS PURCHASER AGENT
Reel/Frame 071276/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2023
From: PIFERI, PETER G.
To: MRI INTERVENTIONS, INC.
Reel/Frame 063547/0809 →
CHANGE OF NAME Recorded May 5, 2023
From: MRI INTERVENTIONS, INC.
To: CLEARPOINT NEURO, INC.
Reel/Frame 063557/0633 →
Continuity (4)
Continuation 16887161 · May 29, 2020
Provisional Application 62937911 · Nov 20, 2019
Provisional Application 62912324 · Oct 8, 2019
Related Publication 20230270976A1 · Aug 31, 2023
References Cited (269)
US 3352306A · Hrisch · 1967 [cited by applicant]
US 3540447A · Howe · 1970 [cited by applicant]
US 3824157A · Macur · 1974 [cited by applicant]
US 3856009A · Winnie · 1974 [cited by applicant]
US 4149535A · Volder · 1979 [cited by applicant]
US 4239042A · Asai · 1980 [cited by applicant]
US 4265928A · Braun · 1981 [cited by applicant]
US 4327722A · Groshong et al. · 1982 [cited by applicant]
US 4449532A · Storz · 1984 [cited by applicant]
US 4531943A · Van Tassel et al. · 1985 [cited by applicant]
US 4543091A · Froning et al. · 1985 [cited by applicant]
US 4543092A · Mehler et al. · 1985 [cited by applicant]
US 4597421A · Wells · 1986 [cited by applicant]
US 4623789A · Ikeda et al. · 1986 [cited by applicant]
US 4629450A · Suzuki et al. · 1986 [cited by applicant]
US 4705511A · Kocak · 1987 [cited by applicant]
US 4738658A · Magro et al. · 1988 [cited by applicant]
US 4739768A · Engelson et al. · 1988 [cited by applicant]
US 4781691A · Gross · 1988 [cited by applicant]
US 4820349A · Saab · 1989 [cited by applicant]
US 4846799A · Tanaka et al. · 1989 [cited by applicant]
US 4897077A · Cicciu et al. · 1990 [cited by applicant]
US 4903707A · Knute et al. · 1990 [cited by applicant]
US 4955863A · Walker et al. · 1990 [cited by applicant]
US 4968306A · Huss et al. · 1990 [cited by applicant]
US 4978334A · Toye et al. · 1990 [cited by applicant]
US 4995866A · Amplatz et al. · 1991 [cited by applicant]
US 5069673A · Shwab · 1991 [cited by applicant]
US 5380292A · Wilson · 1995 [cited by applicant]
US 5562626A · Sanpietro · 1996 [cited by applicant]
US 5699801A · Atalar et al. · 1997 [cited by applicant]
US 5720720A · Laske et al. · 1998 [cited by applicant]
US 5722985A · Pettus · 1998 [cited by applicant]
US 5792144A · Fischell et al. · 1998 [cited by applicant]
US 5833662A · Stevens · 1998 [cited by applicant]
US 5851203A · Van · 1998 [cited by applicant]
US 5857999A · Quick et al. · 1999 [cited by applicant]
US 5871470A · McWha · 1999 [cited by applicant]
US 5902282A · Balbierz · 1999 [cited by applicant]
US 5919171A · Kira et al. · 1999 [cited by applicant]
US 5928145A · Ocali et al. · 1999 [cited by applicant]
US 5935122A · Fourkas et al. · 1999 [cited by applicant]
US 6020196A · Hu et al. · 2000 [cited by applicant]
US 6026316A · Kucharczyk et al. · 2000 [cited by applicant]
US 6030369A · Engelson et al. · 2000 [cited by applicant]
US 6042579A · Elsberry et al. · 2000 [cited by applicant]
US 6050992A · Nichols · 2000 [cited by applicant]
US 6093180A · Elsberry · 2000 [cited by applicant]
US 6159195A · Ha et al. · 2000 [cited by applicant]
US 6167311A · Rezai · 2000 [cited by applicant]
US 6186986B1 · Berg et al. · 2001 [cited by applicant]
US 6231591B1 · Desai · 2001 [cited by applicant]
US 6263229B1 · Atalar et al. · 2001 [cited by applicant]
US 6284971B1 · Atalar et al. · 2001 [cited by applicant]
US RE37410E · Brem et al. · 2001 [cited by applicant]
US 6309634B1 · Bankiewicz et al. · 2001 [cited by applicant]
US 6336915B1 · Scarfone et al. · 2002 [cited by applicant]
US 6356786B1 · Rezai et al. · 2002 [cited by applicant]
US 6405079B1 · Ansarinia · 2002 [cited by applicant]
US 6438423B1 · Rezai et al. · 2002 [cited by applicant]
US 6454774B1 · Fleckenstein · 2002 [cited by applicant]
US 6461296B1 · Desai · 2002 [cited by applicant]
US 6524299B1 · Tran et al. · 2003 [cited by applicant]
US 6526318B1 · Ansarinia · 2003 [cited by applicant]
US 6533751B2 · Cragg et al. · 2003 [cited by applicant]
US 6539263B1 · Schiff et al. · 2003 [cited by applicant]
US 6551290B1 · Elsberry et al. · 2003 [cited by applicant]
US 6585694B1 · Smith et al. · 2003 [cited by applicant]
US 6606513B2 · Lardo et al. · 2003 [cited by applicant]
US 6609030B1 · Rezai et al. · 2003 [cited by applicant]
US 6628980B2 · Atalar et al. · 2003 [cited by applicant]
US 6641555B1 · Botich et al. · 2003 [cited by applicant]
US 6641564B1 · Kraus · 2003 [cited by applicant]
US 6675033B1 · Lardo et al. · 2004 [cited by applicant]
US 6689142B1 · Tremaglio et al. · 2004 [cited by applicant]
US 6701176B1 · Halperin et al. · 2004 [cited by applicant]
US 6708064B2 · Rezai · 2004 [cited by applicant]
US 6904307B2 · Karmarkar et al. · 2005 [cited by applicant]
US 7037295B2 · Tiernan et al. · 2006 [cited by applicant]
US 7182944B2 · Bankiewicz · 2007 [cited by applicant]
US 7329262B2 · Gill · 2008 [cited by applicant]
US 7341577B2 · Gill · 2008 [cited by applicant]
US 7351239B2 · Gill · 2008 [cited by applicant]
US 7371225B2 · Oldfield et al. · 2008 [cited by applicant]
US 7780692B2 · Nance et al. · 2010 [cited by applicant]
US 7815623B2 · Bankiewicz et al. · 2010 [cited by applicant]
US 7892203B2 · Lenker et al. · 2011 [cited by applicant]
US 7951110B2 · Bishop et al. · 2011 [cited by applicant]
US 8128600B2 · Gill · 2012 [cited by applicant]
US 8175677B2 · Sayler et al. · 2012 [cited by applicant]
US 8195272B2 · Piferi et al. · 2012 [cited by applicant]
US 8315689B2 · Jenkins et al. · 2012 [cited by applicant]
US 8340743B2 · Jenkins et al. · 2012 [cited by applicant]
US 8348892B2 · Lenker et al. · 2013 [cited by applicant]
US 8374677B2 · Piferi et al. · 2013 [cited by applicant]
US 8597277B2 · Lenker et al. · 2013 [cited by applicant]
US 8827987B2 · Fielder et al. · 2014 [cited by applicant]
US 8900214B2 · Nance et al. · 2014 [cited by applicant]
US 9044577B2 · Bishop et al. · 2015 [cited by applicant]
US 9050419B2 · Farnan · 2015 [cited by applicant]
US 9452241B2 · Gill et al. · 2016 [cited by applicant]
US 9498575B2 · Flores · 2016 [cited by applicant]
US 9572928B2 · Shifflette et al. · 2017 [cited by applicant]
US 9610048B2 · Vij et al. · 2017 [cited by applicant]
US 9891296B2 · Piferi · 2018 [cited by applicant]
US 10105485B2 · Piferi et al. · 2018 [cited by applicant]
US 10576247B2 · Flores et al. · 2020 [cited by applicant]
US 10786325B1 · Osa · 2020 [cited by applicant]
US 10905497B2 · Pandey et al. · 2021 [cited by applicant]
US 11022664B2 · Piferi · 2021 [cited by applicant]
US 20020052576A1 · Massengale · 2002 [cited by examiner]
US 20020087152A1 · Mikus et al. · 2002 [cited by applicant]
US 20020091372A1 · Cragg et al. · 2002 [cited by applicant]
US 20020095081A1 · Vilsmeier · 2002 [cited by applicant]
US 20020114780A1 · Bankiewicz et al. · 2002 [cited by applicant]
US 20020141980A1 · Bankiewicz et al. · 2002 [cited by applicant]
US 20020183763A1 · Callol et al. · 2002 [cited by applicant]
US 20030028095A1 · Tulley et al. · 2003 [cited by applicant]
US 20030050557A1 · Susil et al. · 2003 [cited by applicant]
US 20030073934A1 · Putz · 2003 [cited by applicant]
US 20030130575A1 · Desai · 2003 [cited by applicant]
US 20030216714A1 · Gill · 2003 [cited by applicant]
US 20040044329A1 · Trudell · 2004 [cited by applicant]
US 20040046557A1 · Karmarkar et al. · 2004 [cited by applicant]
US 20040064098A1 · Cuschieri et al. · 2004 [cited by applicant]
US 20040068190A1 · Cespedes · 2004 [cited by applicant]
US 20040092879A1 · Kraus et al. · 2004 [cited by applicant]
US 20040199129A1 · Dimatteo · 2004 [cited by applicant]
US 20040209810A1 · Gill et al. · 2004 [cited by applicant]
US 20040215162A1 · Putz · 2004 [cited by examiner]
US 20040249261A1 · Torchia · 2004 [cited by examiner]
US 20050004504A1 · Frye · 2005 [cited by examiner]
US 20050112065A1 · Drummond et al. · 2005 [cited by applicant]
US 20050148865A1 · Weber · 2005 [cited by applicant]
US 20050154297A1 · Gill · 2005 [cited by applicant]
US 20050256503A1 · Hall · 2005 [cited by applicant]
US 20050277889A1 · Neidert et al. · 2005 [cited by applicant]
US 20060052750A1 · Lenker et al. · 2006 [cited by applicant]
US 20060073101A1 · Oldfield et al. · 2006 [cited by applicant]
US 20060129126A1 · Kaplitt et al. · 2006 [cited by applicant]
US 20060135945A1 · Bankiewicz et al. · 2006 [cited by applicant]
US 20060217664A1 · Hattler et al. · 2006 [cited by applicant]
US 20070088295A1 · Bankiewicz · 2007 [cited by applicant]
US 20070110798A1 · Drummond et al. · 2007 [cited by applicant]
US 20070167736A1 · Dietz et al. · 2007 [cited by applicant]
US 20070179455A1 · Geliebter et al. · 2007 [cited by applicant]
US 20070250021A1 · Brimhall et al. · 2007 [cited by applicant]
US 20070254842A1 · Bankiewicz · 2007 [cited by applicant]
US 20080103456A1 · Johnson et al. · 2008 [cited by applicant]
US 20080119821A1 · Agnihotri et al. · 2008 [cited by applicant]
US 20080215008A1 · Nance et al. · 2008 [cited by applicant]
US 20080228168A1 · Mittermeyer et al. · 2008 [cited by applicant]
US 20080319377A1 · Keenan · 2008 [cited by applicant]
US 20090082783A1 · Piferi · 2009 [cited by applicant]
US 20090088695A1 · Kapur et al. · 2009 [cited by applicant]
US 20090088730A1 · Hoofnagle et al. · 2009 [cited by applicant]
US 20090112084A1 · Piferi et al. · 2009 [cited by applicant]
US 20090118610A1 · Karmarkar et al. · 2009 [cited by applicant]
US 20090143764A1 · Nelson · 2009 [cited by applicant]
US 20090171184A1 · Jenkins et al. · 2009 [cited by applicant]
US 20090177077A1 · Piferi et al. · 2009 [cited by applicant]
US 20090198218A1 · Gill et al. · 2009 [cited by applicant]
US 20090209937A1 · Rogawski et al. · 2009 [cited by applicant]
US 20090281453A1 · Tsonton et al. · 2009 [cited by applicant]
US 20100130958A1 · Kang et al. · 2010 [cited by applicant]
US 20100198052A1 · Jenkins et al. · 2010 [cited by applicant]
US 20100217228A1 · Grahn et al. · 2010 [cited by applicant]
US 20100217236A1 · Gill et al. · 2010 [cited by applicant]
US 20100228122A1 · Keenan et al. · 2010 [cited by applicant]
US 20100317961A1 · Jenkins et al. · 2010 [cited by applicant]
US 20100318061A1 · Derrick et al. · 2010 [cited by applicant]
US 20100318064A1 · Derrick et al. · 2010 [cited by applicant]
US 20110168176A1 · Kholtchanski · 2011 [cited by examiner]
US 20110282319A1 · Gill · 2011 [cited by applicant]
US 20120123391A1 · Gill et al. · 2012 [cited by applicant]
US 20120310182A1 · Fielder et al. · 2012 [cited by applicant]
US 20130006095A1 · Jenkins et al. · 2013 [cited by applicant]
US 20130030408A1 · Piferi et al. · 2013 [cited by applicant]
US 20130150712A1 · Field · 2013 [cited by applicant]
US 20130226094A1 · Ahmed et al. · 2013 [cited by applicant]
US 20140163367A1 · Eskuri · 2014 [cited by applicant]
US 20140171760A1 · Singh et al. · 2014 [cited by applicant]
US 20140257168A1 · Gill · 2014 [cited by applicant]
US 20140343500A1 · Fielder et al. · 2014 [cited by applicant]
US 20150011938A1 · Gill et al. · 2015 [cited by applicant]
US 20150080708A1 · Piferi · 2015 [cited by applicant]
US 20150080814A1 · Lambert · 2015 [cited by examiner]
US 20150374908A1 · Piferi · 2015 [cited by applicant]
US 20160074626A1 · Weadock et al. · 2016 [cited by applicant]
US 20160100895A1 · Piferi et al. · 2016 [cited by applicant]
US 20160213312A1 · Singh · 2016 [cited by examiner]
US 20160346505A1 · Gill et al. · 2016 [cited by applicant]
US 20170056617A1 · Thomson et al. · 2017 [cited by applicant]
US 20170197017A1 · Martin · 2017 [cited by applicant]
US 20170232229A1 · Flores · 2017 [cited by examiner]
US 20180303560A1 · Pandey et al. · 2018 [cited by applicant]
US 20190255282A1 · Inukai et al. · 2019 [cited by applicant]
US 20190282320A1 · Patwardhan et al. · 2019 [cited by applicant]
US 20190343496A1 · Daly et al. · 2019 [cited by applicant]
US 20190346516A1 · Piferi · 2019 [cited by applicant]
US 20200147299A1 · Piferi · 2020 [cited by applicant]
US 20200229889A1 · Kells et al. · 2020 [cited by applicant]
US 20210187188A1 · Daly et al. · 2021 [cited by applicant]
US 20210318397A1 · Piferi · 2021 [cited by applicant]
US 20210361318A1 · Patzke et al. · 2021 [cited by applicant]
CA 2655515A1 · 2010 [cited by applicant]
EP 1029509A1 · 2000 [cited by applicant]
EP 1334740A1 · 2003 [cited by applicant]
EP 1482851A1 · 2004 [cited by applicant]
EP 1491154A1 · 2004 [cited by applicant]
EP 2558154A2 · 2013 [cited by applicant]
GB 1255551A · 1971 [cited by applicant]
JP 2002509767A · 2002 [cited by applicant]
JP 2004147830A · 2004 [cited by applicant]
WO 9904849A1 · 1999 [cited by applicant]
WO 9949909A2 · 1999 [cited by applicant]
WO 9949909A3 · 1999 [cited by applicant]
WO 02053205A2 · 2002 [cited by applicant]
WO 03077785A1 · 2003 [cited by applicant]
WO 2004031348A2 · 2004 [cited by applicant]
WO 2008020237A2 · 2008 [cited by applicant]
WO 2008020241A2 · 2008 [cited by applicant]
WO 2008144585A1 · 2008 [cited by applicant]
WO 2008144775A1 · 2008 [cited by applicant]
WO 2009042135A2 · 2009 [cited by applicant]
WO 2009047490A2 · 2009 [cited by applicant]
WO 2009066130A1 · 2009 [cited by applicant]
WO 2009101397A1 · 2009 [cited by applicant]
WO 2010040970A2 · 2010 [cited by applicant]
WO 2011098768A1 · 2011 [cited by applicant]
WO 2011098769A1 · 2011 [cited by applicant]
WO 2011130107A2 · 2011 [cited by applicant]
WO 2012178169A2 · 2012 [cited by applicant]
WO 2013050148A1 · 2013 [cited by applicant]
WO 2014089373A1 · 2014 [cited by applicant]
WO 2019030761A1 · 2019 [cited by applicant]
Chen et al. “Combination Therapy with Irinotecan and Protein Kinase C Inhibitors in Malignant Glioma” Cancer 97(9 Suppl):2363-2373 (2003). [cited by applicant]
Chen et al. “Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system” Journal of Neurosurgery 103:311-319 (2005). [cited by applicant]
Cunningham et al. “Distribution of AAV-TK following intracranial convection-enhanced delivery into rats” Cell Transplantation 9(5):585-594 (2000) (Abstract Only). [cited by applicant]
Groothuis, Dennis R. “The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery” Neuro-Oncology 2:45-59 (2000). [cited by applicant]
Hadaczek et al. “Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey Brain” Human Gene Therapy 17:291-302 (2006). [cited by applicant]
Hadaczek et al. “The ‘Perivascular Pump’ Driven by Arterial Pulsation is a Powerful Mechanism for the Distribution of Therapeutic molecules within the Brain” Molecular Therapy 14(1):69-78 (2006). [cited by applicant]
Hanley et al. “Safety and efficacy of minimally invasive surgery plus recombinant tissue plasminogen activator in intracerebral haemorrhage evacuation (MISTIE): a randomised, phase 2 trial” The Lancet Neurology, 15(12):… [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority corresponding to International Patent Application No. PCT/US2020/036741 (16 pages) (mailed Sep. 21, 2020). [cited by applicant]
Krauze et al. “Real-time Imaging and Quantification of Brain Delivery of Liposomes” Pharmaceutical Research 23(11):2493-2504 (2006). [cited by applicant]
Krauze et al. “Reflux-free cannula for convection-enhanced high speed delivery of therapeutic agents” Journal of Neurosurgery 103:923-929 (2005). [cited by applicant]
Laske et al. “Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging” Journal of Neurosurgery 87:586-594 (… [cited by applicant]
Lieberman et al. “Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion” Journal of Neurosurgery 82:1021-1029 (1995). [cited by applicant]
Lonser et al. “Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion” Journal of Neurosurgery 97:905-913 (2002). [cited by applicant]
Mamot et al. “Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery” Journal of Neuro-Oncology 68:1-9 (2004). [cited by applicant]
Mardor et al. “Monitoring Response to Convection-enhanced Taxol Delivery in Brain Tumor Patients Using Diffusion-weighted Magnetic Resonance Imaging” Cancer Research 61:4971-4973 (2001). [cited by applicant]
Marshall et al. “Biocompatibility of Cardiovascular Gene Delivery Catheters with Adenovirus Vectors: An Important Determinant of the Efficiency of Cardiovascular Gene Transfer” Molecular Therapy 1(5):423-429 (2000). [cited by applicant]
Morrison et al. “Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics” American Journal of Physiology—Regulatory, Integrative and Comparative Physiology 277:R1218-R1… [cited by applicant]
Morrison et al. “High-flow microinfusion: tissue penetration and pharmacodynamics” American Journal of Physiology—Regulatory, Integrative and Comparative Physiology 266:R292-R305 (1994). [cited by applicant]
Mould et al. “Minimally Invasive Surgery plus rt-PA for Intracerebral Hemorrhage Evacuation (MISTIE) Decreases Perihematomal Edema” Stroke, 44(3):627-634 (2013). [cited by applicant]
Naimark et al. “Adenovirus-Catheter Compatibility Increases Gene Expression After Delivery to Porcine Myocardium” Human Gene Therapy 14:161-166 (2003). [cited by applicant]
Pardridge, William M. “Drug Delivery to the Brain” Journal of Cerebral Blood Flow and Metabolism 17:713-731 (1997). [cited by applicant]
Pardridge, William M. “The Blood-Brain Barrier: Bottleneck in Brain Drug Development” NeuroRx: The Journal of the American Society for Experimental Neuro Therapeutics 2:3-14 (2005). [cited by applicant]
Patel et al. “Intraputamenal Infusion of Glial Cell Line-Derived Neurotrophic Factor in Pd: A Two-Year Outcome Study” Annals of Neurology 57:298-302 (2005). [cited by applicant]
Qureshi et al. “Multicolumn Infusion of Gene Therapy Cells into Human Brain Tumors: Technical Report” Neurosurgery 46(3):663-669 (2000) (Abstract Only). [cited by applicant]
Richardson et al. “Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease” Molecular Therapy 19(6):1048-1057 (2011). [cited by applicant]
Rogawski, Michael A. “Convection-Enhanced Delivery in the Treatment of Epilepsy” Neurotherapeutics: The Journal of the American Society for Experimental Neuro Therapeutics 6:344-351 (2009). [cited by applicant]
Saito et al. “Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging” Cancer Research 64:2572-2579 (2004). [cited by applicant]
Tsui et al. “Stability of Adenoviral Vectors Following Catheter Delivery” Molecular Therapy 3(1):122-125 (2001). [cited by applicant]
Vogelbaum, Michael A. “Convection enhanced delivery for the treatment of malignant gliomas: symposium review” Journal of Neuro-Oncology 73:57-69 (2005). [cited by applicant]
Bankiewicz, Krys S., et al., “Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach”, Experimental Neur… [cited by applicant]
Chen, Michael Y., et al., “Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time”, Journal … [cited by applicant]
Saito, Ryuta , et al., “Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft mo… [cited by applicant]
Westphal, Manfred , et al., “Perspectives of cellular and molecular neurosurgery”, Journal of Neuro-Oncology, 70(2), 2004, 255-269. [cited by applicant]